In LAM patients, circulating VEGF-D (Vascular Endothelial Growth Factor D) is increased in the blood and is associated with lymphangiogenesis, a major pathogenic mechanism in LAM progression7,8. This evidence concerns the gene VEGFD and lymphangioleiomyomatosis.